{
    "name": "budesonide rectal",
    "comment": "Rx",
    "other_names": [
        "Uceris Rectal Foam"
    ],
    "classes": [
        "Corticosteroids",
        "Rectal"
    ],
    "source": "https://reference.medscape.com/drug/uceris-rectal-foam-budesonide-rectal-999966",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Rectal foam is likely to result in budesonide in human milk as budesonide delivered by inhalation from a dry-powder inhaler is present in human milk at low concentrations"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Rectal foam is likely to result in budesonide in human milk as budesonide delivered by inhalation from a dry-powder inhaler is present in human milk at low concentrations"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Long-term use of corticosteroids may cause hypercorticism and adrenal suppression",
                "Taper systemic corticosteroids slowly when transitioning from corticosteroids with higher systemic effects to those with lower effects (eg, budesonide rectal); symptoms attributed to withdrawal of steroid therapy, including those of acute adrenal suppression or benign intracranial hypertension, may develop",
                "Corticosteroids (prolonged use or high doses) are known to be immunosuppressive; monitor patients with active or quiescent tuberculosis infection, ocular herpes simplex, or untreated fungal, bacterial, systemic viral, or parasitic infections",
                "Monitor patients with hypertension, diabetes mellitus, osteoporosis, peptic ulcer, glaucoma, or cataracts; any family history of diabetes or glaucoma; or with any other conditions in which glucocorticosteroids may have unwanted effects",
                "Moderate-to-severe hepatic impairment; monitor for increased signs and/or symptoms of hypercorticism",
                "Avoid use of strong CYP3A4 inhibitors (eg, ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, erythromycin, grapefruit juice) during 6-week treatment period; may increase budesonide systemic exposure",
                "Rectal foam is flammable; store away from flame or heat sources"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "macimorelin",
            "description": {
                "common": "budesonide rectal, macimorelin. unspecified interaction mechanism. Avoid or Use Alternate Drug. Drugs that directly affect the pituitary secretion of growth hormone (GH) may impact the accuracy of the macimorelin diagnostic test. Allow sufficient washout time of drugs affecting GH growth hormone release before administering prior to administration of macimorelin. Drugs that directly affect the pituitary secretion of growth hormone (GH) may impact the accuracy of the macimorelin diagnostic test. Allow sufficient washout time of drugs affecting GH release before administering macimorelin."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Decreased blood cortisol",
            "percent": "17"
        },
        {
            "name": "Adrenal insufficiency",
            "percent": "4"
        },
        {
            "name": "Nausea",
            "percent": "2"
        },
        {
            "name": "Insomnia",
            "percent": "0.4"
        },
        {
            "name": "Sleep disorder",
            "percent": "0.4"
        },
        {
            "name": "Acne",
            "percent": "0.4"
        },
        {
            "name": "Depression",
            "percent": "0.4"
        },
        {
            "name": "Hyperglycemia",
            "percent": "0.4"
        },
        {
            "name": "Cardiac disorders",
            "percent": null
        },
        {
            "name": "Hypertension",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Pancreatitis",
            "percent": null
        },
        {
            "name": "General disorders and administration",
            "percent": null
        },
        {
            "name": "site conditions",
            "percent": null
        },
        {
            "name": "Pyrexia",
            "percent": null
        },
        {
            "name": "peripheral edema",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Anaphylactic reactions",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "benign intracranial hypertension",
            "percent": null
        },
        {
            "name": "Psychiatric disorders",
            "percent": null
        },
        {
            "name": "Mood swings",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Pruritus",
            "percent": null
        },
        {
            "name": "maculopapular rash",
            "percent": null
        },
        {
            "name": "allergic dermatitis",
            "percent": null
        }
    ]
}